RxDoctor Payments Data

Philippe Mercier

Neurological Surgery · Saint Louis, MONPI 1053710160

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. GT Medical Technologies, Inc accounts for 64.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $11,389 and has fallen 95.1% since, to $562 in 2025.

$18,021in general payments, 2019–2025

Across 96 payments — averaging $187.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GT Medical Technologies, Inc$12K
  • Medtronic$2K
  • Neuropace, Inc.$2K
  • Zimmer Biomet$616
  • Globus Medical$587
  • Zavation Medical Products, LLC$335
  • plus $613 from 4 others
$99,866in research payments, 2019–2025

Across 8 payments — averaging $12,483 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Tanabe Pharma America, Inc.$71K
  • Mitsubishi Tanabe Pharma Development America, Inc.$20K
  • Vertex$8K
  • Innovative Surgical Designs, Inc.$216

What the payments were for

  • Consulting fees$6,25035%
  • Travel & lodging$7,58742%
  • Food & beverage$3,86421%
  • Entertainment$3202%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,021 in reported general payments places this provider in the 80th percentile of 172 neurological surgery providers in Missouri.

See all neurological surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$44,310
Medicare patients
61
Services billed
123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$181

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →